SMC issues advice on four medicines (May 2017)
Published: 11 May 2017
The Scottish Medicines Consortium (SMC) has issued advice on four different medicines, advising healthcare professionals as to whether they have been accepted for use, accepted for restricted use, or not recommended for use in NHS Scotland.
The medicines are listed under the following British National Formulary categories:
- Sex hormones
- micronised progesterone—accepted for use.
- Miscellaneous ophthalmic presentations
Musculoskeletal and joint diseases
- Drugs used in rheumatic diseases and gout
- belimumab—accepted for restricted use.
The SMC aims to ensure that newly licensed medications representing good value for money are accepted for routine use in NHS Scotland as quickly as possible. It does this by bringing together a consortium that is made up of lead clinicians, pharmacists, and health economists, as well as representatives from health boards, the pharmaceutical industry, and the public.